Bigul

Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Loss of share certificate intimation
25-03-2022

Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
22-03-2022

Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
01-03-2022

Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
23-02-2022

Jyothy Labs Ltd - 532926 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
10-02-2022

Accumulate Jyothy Labs target of Rs 165: Geojit

Geojit recommended Accumulate rating on Jyothy Labs with a target price of Rs 165 in its research report dated January 28, 2022.
02-02-2022

Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication - Un-audited Financial Results of the Company for the quarter and nine months ended December 31, 2021
24-01-2022

Earnings Call for Q3FY22 of Jyothy Labs

Conference Call with Jyothy Labs Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.
22-01-2022

Jyothy Labs Standalone December 2021 Net Sales at Rs 528.65 crore, up 12.62% Y-o-Y

NULL
21-01-2022

Jyothy Labs Ltd - 532926 - Announcement under Regulation 30 (LODR)-Investor Presentation

Presentation on the Company's performance for the quarter and nine months ended December 31, 2021.
21-01-2022